A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors
Clinical trial NCT06041035 · UNKNOWN
Trial details
- NCT number
- NCT06041035
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2024-10-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.